APB Study: Apixaban Pharmacokinetics in Bariatric Patients

Trial Profile

APB Study: Apixaban Pharmacokinetics in Bariatric Patients

Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2017

At a glance

  • Drugs Apixaban (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Acronyms APB
  • Most Recent Events

    • 12 Dec 2017 Status changed from not yet recruiting to recruiting.
    • 29 Aug 2016 Planned number of patients changed from 50 to 30.
    • 29 Aug 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top